Pharmacogenomics in kidney transplant recipients and potential for integration into practice

WHAT IS KNOWN AND OBJECTIVE: Pharmacogenomic biomarkers are now used in many clinical care settings and represent one of the successes of precision medicine. Genetic variants are associated with pharmacokinetic and pharmacodynamic changes leading to medication adverse effects and changes in clinical...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Pharm Ther
Glavni autori: Nguyen, Tam T., Pearson, Rachael A., Mohamed, Moataz E., Schladt, David P., Berglund, Danielle, Rivers, Zachary, Skaar, Debra J., Wu, Baolin, Guan, Weihua, van Setten, Jessica, Keating, Brendan J., Dorr, Casey, Remmel, Rory P., Matas, Arthur J., Mannon, Roslyn B., Israni, Ajay K., Oetting, William S., Jacobson, Pamala A.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719579/
https://ncbi.nlm.nih.gov/pubmed/32662547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13223
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items